[PDF][PDF] PANDA Analysis Plan
GH Lewis - 2017 - discovery.ucl.ac.uk
PANDA ANALYSIS PLAN PANDA: What are the indications for Prescribing ANtiDepressAnts
that will lead to a clinical benefit? TRIAL Page 1 PANDA ANALYSIS PLAN PANDA: What are …
that will lead to a clinical benefit? TRIAL Page 1 PANDA ANALYSIS PLAN PANDA: What are …
[HTML][HTML] Phase 2: the PANDA cohort study–using both quantitative and qualitative methods
L Duffy, G Lewis, A Ades, R Araya, J Bone… - … with sertraline for …, 2019 - ncbi.nlm.nih.gov
Phase 2: the PANDA cohort study – using both quantitative and qualitative methods -
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the …
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the …
[HTML][HTML] Phase 3: the PANDA randomised controlled trial
L Duffy, G Lewis, A Ades, R Araya, J Bone… - … with sertraline for …, 2019 - ncbi.nlm.nih.gov
Duffy L, Lewis G, Ades A, et al. Antidepressant treatment with sertraline for adults with
depressive symptoms in primary care: the PANDA research programme including RCT …
depressive symptoms in primary care: the PANDA research programme including RCT …
[HTML][HTML] What predicts response to sertraline for people with depression in primary care? a secondary data analysis of moderators in the PANDA trial
Purpose Antidepressants are a first-line treatment for depression, yet many patients do not
respond. There is a need to understand which patients have greater treatment response but …
respond. There is a need to understand which patients have greater treatment response but …
[HTML][HTML] A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus …
Background Depressive symptoms are usually managed within primary care and
antidepressant medication constitutes the first-line treatment. It remains unclear at present …
antidepressant medication constitutes the first-line treatment. It remains unclear at present …
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT
Background Despite a growing number of prescriptions for antidepressants (over 70 million
in 2018), there is uncertainty about when people with depression might benefit from …
in 2018), there is uncertainty about when people with depression might benefit from …
[HTML][HTML] Phase 1: using previously collected data
L Duffy, G Lewis, A Ades, R Araya, J Bone… - … with sertraline for …, 2019 - ncbi.nlm.nih.gov
Phase 1: using previously collected data - Antidepressant treatment with sertraline for adults
with depressive symptoms in primary care: the PANDA research programme including RCT …
with depressive symptoms in primary care: the PANDA research programme including RCT …
[PDF][PDF] George Salaminios1, Larisa Duffy1, Anthony Ades2, Ricardo Araya3, Katherine S. Button4, Rachel Churchill5, Tim Croudace6, Catherine Derrick2, Padraig …
D Riozzie, J Robinson10, D Sharp, L Thomas… - 2017 - trialsjournal.biomedcentral.com
Background: Depressive symptoms are usually managed within primary care and
antidepressant medication constitutes the first-line treatment. It remains unclear at present …
antidepressant medication constitutes the first-line treatment. It remains unclear at present …
[HTML][HTML] From the bench to the trench: a comparison of sertraline treatment of major depression in clinical and research patient samples
RB Lydiard, P Perera, E Batzar… - The Primary Care …, 1999 - legacy.psychiatrist.com
Background: New medications that enter the marketplace have been tested almost
exclusively in controlled clinical trials conducted in specialty research settings. There is …
exclusively in controlled clinical trials conducted in specialty research settings. There is …
[引用][C] Advantages and limitations of real world trials on the treatment of depression
HJ Möller - The International Journal of …, 2008 - search.proquest.com
Methods: We have used logistic regression and recursive partitioning analyses to evaluate
whether specific clinical, demographic, or prior treatment features would predict remission or …
whether specific clinical, demographic, or prior treatment features would predict remission or …